Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Si-Bone (SIBN) Cash & Equivalents (2017 - 2026)

Si-Bone has reported Cash & Equivalents over the past 10 years, most recently at $29.0 million for Q1 2026.

  • For Q1 2026, Cash & Equivalents fell 29.65% year-over-year to $29.0 million; the TTM value through Mar 2026 reached $29.0 million, down 29.65%, while the annual FY2025 figure was $33.5 million, 4.08% down from the prior year.
  • Cash & Equivalents for Q1 2026 was $29.0 million at Si-Bone, down from $33.5 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $110.8 million in Q2 2023 and troughed at $18.9 million in Q3 2022.
  • A 5-year average of $34.3 million and a median of $27.8 million in 2025 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: soared 355.67% in 2023 and later plummeted 76.92% in 2024.
  • Year by year, Cash & Equivalents stood at $20.7 million in 2022, then soared by 60.6% to $33.3 million in 2023, then increased by 5.04% to $34.9 million in 2024, then decreased by 4.08% to $33.5 million in 2025, then decreased by 13.57% to $29.0 million in 2026.
  • Business Quant data shows Cash & Equivalents for SIBN at $29.0 million in Q1 2026, $33.5 million in Q4 2025, and $26.5 million in Q3 2025.